Sort   by:  
 Page size 
UnknownHigh expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo.
Not available
S-EPMC7593222 | biostudies-literature
UnknownA multi-ethnic analysis of immune-related gene expression signatures in patients with ovarian clear cell carcinoma.
Not available
S-EPMC9539643 | biostudies-literature
UnknownPrevalence and outcomes of germline pathogenic variants of homologous recombination repair genes in ovarian cancer.
Not available
S-EPMC11611769 | biostudies-literature
UnknownReal-World Treatments and Clinical Outcomes in Advanced NSCLC without Actionable Mutations after Introduction of Immunotherapy in Japan.
Not available
S-EPMC9220782 | biostudies-literature
UnknownA common deletion at BAK1 reduces enhancer activity and confers risk of intracranial germ cell tumors.
Not available
S-EPMC9346128 | biostudies-literature
UnknownA new risk-assessment tool for venous thromboembolism in advanced lung cancer: a prospective, observational study.
Not available
S-EPMC8981807 | biostudies-literature
UnknownRARE TUMOURS
Not available
S-EPMC4046297 | biostudies-literature
Sort   by:  
 Page size